Biocon Biologics News and Activities

Biocon Biologics is owned by Biocon.

Biocon is one of the...

• Nifty 500;
• TOB Iconic 10,000.

Biocon is a company listed under the stock ticker BIOCON (IN).

Biocon has a direct presence in 2 countries.

Biocon has 3 subsidiaries including Bicara Therapeutics, Biocon Biologics and Syngene.

They are in:

• Biotechnology75%
• Pharmaceuticals25%

View the org chart displaying its 16 main executives

Most searched biographies at Biocon Biologics

• Shreehas Tambe, Managing Director and Chief Executive Officer
• Arun Chandavarkar, Non-Executive Director
• Joshua Salsi, Head, North America

Popular executive movements at Biocon Biologics

• Deepak Dobriyal has joined the company as Global Head of Talent and Human Resources Transformation  (posted on December 19 2025).
• Kedar Upadhye has joined the company as Chief Financial Officer, Combined Business  (posted on December 11 2025).
• Neelkanth Chandgothia has joined the company as Global Head, Corporate Finance  (posted on October 13 2025).

Popular executive movements at Biocon

• Karthik Sm who was Head of Human Resources, Global Operations and Enabling, becomes Head of Human Resources, India, Malaysia and Emerging Markets  (posted on April 22 2026).
• Kedar Upadhye who is Chief Financial Officer, Combined Business, will be promoted to Chief Financial Officer on Apr. 1, 2026  (posted on March 27 2026).
• Shreehas Tambe who is Chief Executive Officer, Biocon Biologics, will become Director and Chief Executive Officer, Biocon Biologics on Apr. 1, 2026  (posted on March 27 2026).

Click here to view some more movements at Biocon

Create your alert
to follow the executive moves at Biocon Biologics.

Biocon has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Biocon Biologics

Social media about Biocon Biologics

• Biocon Biologics on Wikipedia, Google News & Yahoo Finance
• Biocon Biologics on LinkedIn, X (Twitter) & YouTube